Aardvark Therapeutics, Inc. Common Stock (AARD) vs Coya Therapeutics, Inc. (COYA)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Coya Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
COYA
Coya Therapeutics, Inc.
$4.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AARD vs COYA
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)COYA -29.1% (-15.8%/yr)COYA compounded faster over this window
AARD COYA
AARD vs COYA: by the numbers
- •AARD is the larger company ($114M vs $114M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -270.22% net margin).
Metrics side by side
Valuation
| Metric | AARD | COYA |
|---|---|---|
| P/S ratio | N/A | 14.19 |
| P/B ratio | 1.53 | 0.00 |
Profitability
| Metric | AARD | COYA |
|---|---|---|
| Gross margin | 0.00% | 99.91% |
| Operating margin | 0.00% | -255.05% |
| Net margin | 0.00% | -270.22% |
| ROE | -93.44% | -0.05% |
| ROIC | -97.99% | -0.05% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROECoya Therapeutics ROEAardvark Therapeutics, Inc. Common Stock operating marginCoya Therapeutics operating marginAardvark Therapeutics, Inc. Common Stock revenue growthCoya Therapeutics revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowCoya Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.